Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo

Blood

Volumn 100, Issue 13, 2002, Pages 4640-4648

  Pace, Betty S ^a,b,c,d   White, Gary L ^a,b,c,d   Dover, George J ^a,b,c,d   Boosalis, Michael S ^a,b,c,d   Faller, Douglas V ^a,b,c,d   Perrine, Susan P ^a,b,c,d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF SOUTH ALABAMA   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIMETHYL 2 PHENYLACETIC ACID; 2 METHYLBUTYRIC ACID; 2,2 DIMETHYLBUTYRIC ACID; 3 (3,4 DIMETHOXYPHENYL)PROPIONIC ACID; 3 3 PYRIDYL 2 PROPENOIC ACID; 3,5 DIMETHOXY 4 HYDROCINNAMIC ACID; 4 (3,4 DIMETHOXYPHENYL)BUTYRIC ACID; ACID; ACRYLIC ACID DERIVATIVE; ALPHA AMINO N BUTRYIC ACID; ARGININE BUTYRATE; BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; CINNAMIC ACID; GAMMA GLOBIN; HEMOGLOBIN; HYDROCINNAMIC ACID DERIVATIVE; HYDROXAMIC ACID DERIVATIVE; KEMP TRIACID; LEVULINIC ACID; LUCIFERASE; MESSENGER RNA; PHENOXYACETIC ACID; PROPIONIC ACID DERIVATIVE; RECOMBINANT ERYTHROPOIETIN; SHORT CHAIN FATTY ACID; SODIUM ALPHA METHYLHYDROCINNAMATE; SODIUM BUTYRYLHYDROXAMATE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INDUCTION; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FETUS; GENE LOCUS; HEMATOCRIT; IN VIVO STUDY; MITOSIS INHIBITION; MOUSE; NONHUMAN; PHLEBOTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RETICULOCYTE COUNT; RNA SYNTHESIS;

EID: 0037114756     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-02-0353     Document Type: Article

References (52)

1. Steinberg MH, Rodgers GP. Pharmacologic modulation of fetal hemoglobin. Medicine. 2001;80:328-344.
2. Bunn HF. Induction of fetal hemoglobin in sickle cell disease, Blood. 1999;93:1787-1789.
3. Stamatoyannopoulos G, Nienhuis AW. Therapeutic approaches to hemoglobin switching in treatment of the hemoglobinopathies. Ann Rev Med. 1992;43:497-522.
4. Perrine RP, Brown MJ, Clegg JB, Weatherall DJ, May A. Benign sickle cell anemia. Lancet. 1972;2:1163-1167.
5. Brittenham G, Lozoff B, Harris JW, Sharma VS, Narasimhan S. Sickle cell anemia and trait in a population in southern India. Am J Hematol. 1977;2:25-32.
6. Noguchi CT, Rodgers GP, Schechter AN. Levels of fetal hemoglobin necessary for treatment of sickle cell disease, N Engl J Med. 1988;318:96-99.
7. Pembrey ME, Wood WG, Weatherall DJ, Perrine RP. Fetal hemoglobin production and the sickle gene in southern India. Br J Haematol. 1977;2:25-32.
8. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. N Engl J Med. 1991;325:11-16.
9. McDonagh KT, Dover GJ, Donahue RE, et al. Hydroxyurea-induced Hb F production in anemic primates: Augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate. Exp Hematol. 1992;20:1156-1164.
10. Papayannopoulou T, Vichinsky E, Stamatoyannopoulos G. Fetal hemoglobin production during acute erythroid expansion. Br J Haematol. 1980;44:535-538.
11. Letvin NL, Linch DC, Beardsley PG, McIntyre KW, Nathan DG. Augmentation of fetal hemoglobin in anemic monkeys by hydroxyurea. N Engl J Med. 1984;310:869-874.
12. Papayannopoulou T, Torrealba de RA, Veith RW, Knitter G, Stamatoyannopoulos G. Arabinosylcytosine induces fetal hemoglobin in baboons by perturbing erythroid cell differentiation kinetics. Science. 1984;224:617-618.
13. Veith RW, Papayannopoulou T, Kurachi S, Stamatoyannopoulos G. Treatment of baboons with vinblastin: Insights into the mechanisms of pharmacologic stimulation with HbF in the adult. Blood. 1985;66:456-459.
14. Al-Khatti A, Veith RW, Papayannopoulou T, Fritsch EF, Goldwasser E, Stamatoyannopoulos G. Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons. N Engl J Med. 1987;317:415-419.
15. Al-Khatti A, Papayannopoulou T, Knitter G, Fritsch EF Stamatoyannopoulos G. Cooperative enhancement of F-cell formation in baboons treated with erythropoietin and hydroxyurea. Blood. 1988;72:817-821.
16. Charache S, Dover GJ, Moyer MA, Moore JW. Hydroxyurea-induced augmentation of fetal hemoglobin production in sickle cell anemia. Blood. 1987;69:109-116.
17. Steinberg MH, Lu ZH, Barton FB, Terrin ML, Charache S, Dover GJ. Fetal hemoglobin in sickle cell anemia: Determinants of response to hydroxyurea: Multicenter Study of Hydroxyurea. Blood. 1997;89:1078-1088.
18. Torrealba de RA, Papayannopoulou T, Knapp MS, Fu MF, Knitter G, Stamatoyannopoulos G. Perturbations in the erythroid marrow progenitor cell pools may play a role in the augmentation of Hb F by 5-azacytidine. Blood. 1984;63:201-206.
19. Rodgers GP, Dover GJ, Uyeska N, Noguchi CT, Schechter AN, Nienhuis AW. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. N Engl J Med. 1993;328:73-80.
20. Ginder G, Whitters MJ, Pohlman JK. Activation of a chicken embryonic globin gene in adult erythroid cells by 5-azacytidine and sodium butyrate. Proc Natl Acad Sci U S A. 1984;81:3954-3957.
21. Perrine SP, Rudolph A, Failer DV, et al. Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching. Proc Natl Acad Sci U S A. 1988;85:8540-8542.
22. Perrine SP, Miller BA, Faller DV, et al. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with HbSS and beta-thalassemia. Blood. 1989;74:454-458.
23. Constantoulakis P, Papayannopoulou T, Stamatoyannopoulos G. Alpha amino-n-butyric acid stimulates fetal hemoglobin in the adult. Blood. 1988;72:1961-1967.
24. Constantoulakis P, Knitter G, Stamatoyannopoulos G. On the induction of fetal hemoglobin by butyrates: In vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraC. Blood. 1989;72:1963-1971.
25. Perrine SP, Ginder G, Faller DV, et al. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin gene disorders. N Engl J Med. 1993;328:81-87.
26. Dover GJ, Brusilow S, Charache S. Induction of fetal hemoglobin in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood. 1994;84:339-343.
27. Atweh GF, Sutton M, Nassif I, et al. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell anemia. Blood. 1999;93:1790-1797.
28. Blau CA, Constantoulakis P, Shaw CM, Stamatoyannopoulos G. Fetal hemoglobin induction with butyric acid: Efficacy and toxicity. Blood. 1993;81;529-537.
29. Stamatoyannopoulos G, Blau CA, Nakamoto B, et al. Fetal hemoglobin induction by acetate, a product of butyrate catabolism. Blood. 1994;84:3198-3204.
30. Ikuta T, Kan YW, Swerdlow PS, Faller DV, Perrine SP. Alterations in protein-DNA interactions in the gamma globin gene promoter in response to butyrate therapy. Blood. 1998;92:2924-2933.
31. Little JA, Dempsey NJ, Tuchman M, Ginder GD. Metabolic persistence of fetal hemoglobin. Blood. 1995;85:1712-1718.
32. Fibach E, Prasanna P, Rodgers GP, Samid D. Enhanced fetal hemoglobin production by phenyl-acetate and phenylbutyrate in erythroid progenitors derived from normal donors and patients with sickle cell anemia and beta thalassemia. Blood. 1993;82:2203-2209.
33. Glauber JG, Wandersee NJ, Little JA, Ginder GD. 5′ flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells. Mol Cell Biol. 1991;11:4690-4697.
34. Perrine SP, Dover GJ, Daftari P, et al. Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vitro and in vivo. Br J Haematol. 1994;88:555-561.
35. Collins AF, Dover GJ, Luban NLC. Increased fetal hemoglobin in patients receiving valproic acid for epilepsy. Blood. 1994;84:1690-1693.
36. Cappellini MD, Graziadei G, Ciceri L, et al. Oral isobutyramide therapy in patients with thalassemia intermedia: Results of a phase II open study. Blood Cells Mol Dis. 2000;26:105-111.
37. Pace B, Li Q, Peterson K, Stamatoyannopoulos G. Alpha-amino-n-butyric acid cannot reactivate the silenced gamma gene of the beta locus YAC transgenic mouse. Blood. 1994;84:433-437.
38. Safaya S, Ibrahim A, Rieder DF. Augmentation of gamma-globin gene promoter activity by carboxylic acids and components of the human betaglobin locus control region. Blood. 1994;84:3929-3935.
39. Weinberg RS, Ji X, Sutton M, et al. The rapid increase in γ globin chain synthesis in butyrate responsive sickle cell (SCD) patients may be mediated by translational mechanisms (abstract). Blood. 2001;16:751.
40. Liakopoulou E, Blau CA, Li Q, et al. Stimulation of fetal hemoglobin production by short-chain fatty acids. Blood. 1995;86:3227-3235.
41. Sutton M, Nassif I, Stamatoyannopoulos G, Perrine SP, Atweh GF. Absence of cross-resistance to the Hb F stimulating activities of butyrate and hydroxyurea (abstract). Blood. 1998;92:694.
42. Miller AA, Kurschel E, Osieka R, Schmidt CG. Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Cancer Clin Oncol. 1987;23:1283-1287.
43. Daniel P, Braziek M, Ceruitti L, et al. Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine salts. Clin Chim Acta. 1989;181:225-263.
44. Vaziri C, Stice L, Faller DV. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. Cell Growth Differ. 1998;9:465-474.
45. Torkelson S, White GL, Phipps K, Pantazis C, Perrine SP. Erythroid progenitor proliferation is stimulated by phenoxyacetic and phenylakyl acids. Blood Cells Mol Dis. 1996;22:150-158.
46. Boosalis MS, Ikuta T, Pace BS, Perrine SP. Abrogation of IL-3 requirements and stimulation of hematopoietic cell proliferation in vitro and in vivo by carboxylic acids. Blood Cells Mol Dis. 1997;23:434-442.
47. Boosalis MS, Bandyopadhyay R, Bresnick E, et al. Short chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation. Blood. 2001;97:3259-3267.
48. Skarpidi E, Vassilopoulos G, Li Q, Stamatoyannopoulos G. Novel in vitro assay for the detection of pharmacologic inducers of fetal hemoglobin. Blood. 2000;96:321-326.
49. Steinberg MH, Barton FB, Castro O, Ramirez G, Bellevue R, Terrin ML. Hydroxyurea is associated with reduced mortality in adults with sickle cell anemia (abstract). Blood. 2000;96:485.
50. DeSimone J, Heller P, Hall L, Zwiers D. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc Natl Acad Sci U S A. 1982;79:4428-4431.
51. Ley TJ, DeSimone J, Noguchi CT, et al. 5-Azacytidine increases gamma globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia. Blood. 1983;62:370-375.
52. Koshy M, Dome L, Bressler L, et al. 2-Deoxy-5-azacytidine and fetal hemoglobin production in sickle cell anemia. Blood. 2000;6:2379-2394.